<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET>
  <STUDY accession="ERP112120" alias="ena-STUDY-CURIE-19-11-2018-09:58:11:550-136" broker_name="EGA" center_name="CURIE">
    <IDENTIFIERS>
      <PRIMARY_ID>ERP112120</PRIMARY_ID>
      <SUBMITTER_ID namespace="CURIE">ena-STUDY-CURIE-19-11-2018-09:58:11:550-136</SUBMITTER_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>RNA-seq of Ewing sarcoma tumors (ICGC)</STUDY_TITLE>
      <STUDY_ABSTRACT>Ewing sarcoma (ES) is a primary bone tumor initiated by an EWSR1-ETS gene fusion. To characterize the transcriptome of Ewing sarcoma, RNA-seq was performed.</STUDY_ABSTRACT>
      <STUDY_DESCRIPTION>Ewing sarcoma (ES) is a primary bone tumor initiated by an EWSR1-ETS gene fusion. To characterize the transcriptome of Ewing sarcoma, RNA-seq was performed.</STUDY_DESCRIPTION>
      <CENTER_PROJECT_NAME>RNA-seq of Ewing sarcoma tumors (ICGC)</CENTER_PROJECT_NAME>
      <STUDY_TYPE existing_study_type="Other"/>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
